CORT
Corcept Therapeutics
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: CORT
- PE Ratio
As at Aug 13, 2026, the CORT stock has a price-to-earnings ratio of 208.51. This is based on the current EPS of $0.53 and the stock price of $110.51 per share. An increase of 125% has been recorded in the PE ratio compared to the average of 92.9 of the past four quarters.
CORT PE ratio history
The mean historical PE ratio of Corcept Therapeutics over the last ten years is 40.99. The current 208.51 price-to-earnings ratio is 409% more than the historical average. In the past ten years, CORT's PE ratio reached its highest point in the Jun 2026 quarter at 164.06, with a price of $86.95 and an EPS of $0.53. The Sep 2018 quarter saw the lowest point at 10.54, with a price of $14.02 and an EPS of $1.33.
Corcept Therapeutics PE ratio by year
Maximum annual increase: 92.62% in 2020
Maximum annual decrease: -84.73% in 2017
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 36.63 | -1.88% | $34.8 | $0.95 |
| 2024 | 37.33 | 17.24% | $50.39 | $1.35 |
| 2023 | 31.84 | 48.92% | $32.48 | $1.02 |
| 2022 | 21.38 | 4.75% | $20.31 | $0.95 |
| 2021 | 20.41 | -28.21% | $19.8 | $0.97 |
| 2020 | 28.43 | 92.62% | $26.16 | $0.92 |
| 2019 | 14.76 | -28.18% | $12.1 | $0.82 |
| 2018 | 20.55 | 29.73% | $13.36 | $0.65 |
| 2017 | 15.84 | -84.73% | $18.06 | $1.14 |
| 2016 | 103.71 | N/A | $7.26 | $0.07 |
| 2015 | N/A | N/A | $4.98 | -$0.06 |
| 2014 | N/A | N/A | $3 | -$0.31 |
| 2013 | N/A | N/A | $3.21 | -$0.46 |
| 2012 | N/A | N/A | $1.43 | -$0.41 |
| 2011 | N/A | N/A | $3.42 | -$0.39 |
Corcept Therapeutics PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jun 2026 | 164.06 | 87.22% | $86.95 | $0.53 |
| Mar 2026 | 87.63 | 139.23% | $40.31 | $0.46 |
| Dec 2025 | 36.63 | -55.93% | $34.8 | $0.95 |
| Sep 2025 | 83.11 | 42.68% | $83.11 | $1 |
| Jun 2025 | 58.25 | -35.23% | $73.4 | $1.26 |
| Mar 2025 | 89.94 | 140.93% | $114.22 | $1.27 |
| Dec 2024 | 37.33 | 9.7% | $50.39 | $1.35 |
| Sep 2024 | 34.03 | 27.79% | $46.28 | $1.36 |
| Jun 2024 | 26.63 | 21.6% | $32.49 | $1.22 |
| Mar 2024 | 21.9 | -31.22% | $25.19 | $1.15 |
| Dec 2023 | 31.84 | 2.84% | $32.48 | $1.02 |
| Sep 2023 | 30.96 | 23.84% | $27.25 | $0.88 |
| Jun 2023 | 25 | 1.58% | $22.25 | $0.89 |
| Mar 2023 | 24.61 | 15.11% | $21.66 | $0.88 |
| Dec 2022 | 21.38 | -9.94% | $20.31 | $0.95 |
CORT Price vs fair value
CORT average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of CORT is above its 3, 5 and 10-year historical averages.
PE comparison
Corcept Therapeutics's P/E of 208.51 is above the Healthcare sector, the industry and its peers average.
CORT PE vs peers
Frequently asked questions
What is Corcept Therapeutics's PE ratio?
The price to earnings ratio for CORT stock is 208.51 as of Aug 13, 2026.
What is the 3-year average PE ratio for Corcept Therapeutics (CORT)?
Over the last 3 years, the average PE ratio for CORT stock is 58.53.
What is the 5-year average PE ratio for Corcept Therapeutics (CORT)?
Over the last 5 years, the average PE ratio for CORT stock is 44.26.
What is the highest PE ratio for CORT?
The current PE of 208.51 represents the highest historical value in the last ten years.
How does the current PE ratio for CORT compare to its historical average?
CORT's current price to earnings ratio is 409% above its 10-year historical average.
Why is Corcept Therapeutics's PE ratio so high?
CORT's PE ratio of 208.51 is considered high because the company's stock price is trading at a higher multiple of earnings.
How is CORT's PE ratio calculated (Corcept Therapeutics PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Aug 13, 2026), Corcept Therapeutics's stock price is $110.51. The earnings per share for the trailing twelve months (TTM) ending Jun 2026 is $0.53. Therefore, Corcept Therapeutics's price to earnings ratio for today is 208.51. PE RATIO(208.51) = STOCK PRICE($110.51) / TTM EPS($0.53)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.